Avenue Therapeutics, Inc. Recorded Big Gain
Tue, Jan 17, 2023 at 06:57 PM
Avenue Therapeutics, Inc. (ATXI:NASDAQ) jumped higher at $1.99, a gain of 60.5%. On Tue, Jan 17, 2023, ATXI:NASDAQ touched a New 2-Week High of $1.99. From Tue, Jan 03, 2023, the stock recorded 55.56% Up Days and 60.00% Green Days
The stock spiked on Tue, Oct 04, 2022 at $16.65 with a volume of 10M+.
About Avenue Therapeutics, Inc. (ATXI:NASDAQ)
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl, or IV Tramadol, for the management of moderate to moderately severe postoperative pain.
Top 10 Gainers:
- Celyad SA (CYAD:NASDAQ), 137.8%
- Calyxt, Inc. (CLXT:NASDAQ), 90.25%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 60.48%
- BIT Mining Limited ADS (BTCM:NYSE), 42.02%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 39.69%
- Aterian Inc. (ATER:NASDAQ), 37.35%
- Digihost Technology Inc. (DGHI:NASDAQ), 32.91%
- OneConnect Financial Technology Co., Ltd. (OCFT:NYSE), 32.22%
- Arcimoto, Inc. (FUV:NASDAQ), 31.33%
- RenovoRx Inc. (RNXT:NASDAQ), 31.23%